Common Contracts
2 similar null contracts by Elite Pharmaceuticals Inc /Nv/
AMENDMENT TO THE NOVEMBER 21, 2013 SECURED CONVERTIBLE NOTE TO JERRY TREPPEL DUE NOVEMBER 21, 2016 IN THE PRINCIPAL AMOUNT OF $600,000Elite Pharmaceuticals Inc /Nv/ • February 7th, 2014 • Pharmaceutical preparations
This Amendment, dated as of February 7, 2014 (the “Amendment”), by and between Elite Pharmaceuticals, Inc., a corporation organized under the laws of the State of Nevada, and its wholly-owned subsidiary, Elite Laboratories, Inc., a corporation organized under the laws of the State of Delaware (collectively, the “Company”), and Jerry Treppel (“Holder” and along with the Company, the “Parties”), to that certain November 21, 2013 Secured Convertible Note from the Company to Holder due November 21, 2016 in the principal amount of $600,000 (the “Note”);
AMENDMENT TO THE AUGUST 1, 2013 SECURED CONVERTIBLE NOTE TO MIKAH PHARMA LLC DUE AUGUST 1, 2016 IN THE PRINCIPAL AMOUNT OF $10,000,000Elite Pharmaceuticals Inc /Nv/ • February 7th, 2014 • Pharmaceutical preparations
This Amendment, dated as of February 7, 2014 (the “Amendment”), by and between Elite Pharmaceuticals, Inc., a corporation organized under the laws of the State of Nevada, and its wholly-owned subsidiary, Elite Laboratories, Inc., a corporation organized under the laws of the State of Delaware (collectively, the “Company”), and Mikah Pharma LLC, a limited liability company organized under the laws of the State of Delaware (“Holder” and along with the Company, the “Parties”), to that certain August 1, 2013 Secured Convertible Note from the Company to Holder due August 1, 2016 in the principal amount of $10,000,000 (the “Note”);
